Brief: Rosalind Advisors, Inc. Reports 9.9% Stake In Neuraxis Inc As Of November 12- SEC Filing
Dec 2 (Reuters) - Neuraxis Inc NRXS.A :
* ROSALIND ADVISORS, INC. REPORTS 9.9% STAKE IN NEURAXIS INC
AS OF
NOVEMBER 12- SEC FILING
* ROSALIND ADVISORS: ON NOV 19, APPOINTED AHARON TO NEURAXIS
BOARD, EFFECTIVE JAN 1, 2025
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuraxis
See all newsBrief: Neuraxis Inc Expects Net Sales Of About $1.6 Million For Three Months Ended March 31, 2026
Brief: Neuraxis Reports Strong Fourth Quarter And Full Year 2025 Financial Results
Brief: Neuraxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access To More Patients With Functional Abdominal Pain
Brief: Neuraxis Wins First FDA Nod for FD Pain Treatment
Brief: Neuraxis Terminates License Agreement With Masimo